During this quarter, the company achieved a key milestone of reaching 1,000 DCGI approvals
With this addition, the company’s total Installed MCC Capacity will rise to 30,000 MTPA
IOLCP has reported total income of Rs. 559.06 crores during the period ended June 30, 2025
Tamsulosin, an alpha-1 adrenergic receptor blocker, combined with Dutasteride, a dual 5- alpha-reductase inhibitor, is indicated for the treatment of moderate to severe symptoms of benign prostatic hyperplasia (BPH) in adult men
The India Branded Business delivered a 5% YoY growth, reaching Rs. 599 crore in revenue for the quarter
The companies will now begin detailed contract negotiations and proceed with necessary consultations and approval processes
Fermenta now becomes one of the only two companies globally to hold a CEP for this variant of Vitamin D3
A global platform advancing pharmaceutical collaboration, innovation, and exports—powering healthcare and connecting markets worldwide
The transaction aligns with Aurobindo’s strategic objective to expand its U.S. manufacturing footprint by enhancing its existing domestic capabilities
Subscribe To Our Newsletter & Stay Updated